Get started

DLTR

$DLTR Plummets to Test Major Band of SupportDLTR Shares of the stock dropped hard on Tuesday after company noted cost pressures driven by Chinese tariffs. Stock is testing band of support that has defined the DLTR chart going back 14 months. Dollar Tree, Inc. (NASDAQ:DLTR) just reported Q3 EPS of $1.08 vs. the $1.13 consensus and revenue of $5.75 bln compared to the $5.74 bln estimate. The company has now missed analysts' EPS expectations in back-to-back quarters. A big driver for this underperformance is tariffs on Chinese imports, which impact about 40% of the company’s product margins. For Q4, the company guided for EPS of $1.70-1.80 vs. the $2.03 consensus. This Q3 miss and weak guidance caused DLTR to cut its FY20 EPS guidance to $4.66-4.76 from $4.90-5.11, below the $5.11 consensus. The company anticipates that tariffs will increase cost of goods by $19 mln in Q4, with most of the impact resulting from upcoming List 4 tariffs. The stock was pounded in Tuesday’s action as a result. Dollar Tree, Inc. (NASDAQ:DLTR) frames itself as a company that operates discount variety retail stores. It operates through two segments, Dollar Tree and Family Dollar. Read More at: dailytrendingstocks.com
NASDAQ:DLTR
by GregFolin
DLTR - DAILY CHARTHi, today we are going to talk about the Dollar Tree and its current landscape. Yesterday, the Food and Drug Administration (FDA) that held its committee meeting today for a series of deliberations, among them the FDA issued to the Dollar Tree a warning about the company has sold potentially unsafe drugs in its stores. These drugs had origin on certain manufactures that were warned by the FDA last year over multiples violations. Dollar Tree will disclosure its earnings on Nov. 26 and can disclosure the possibles impacts of FDA warning on its next quarter guidance. Thank you for reading and leave your comments if you like. To have access to our exclusive contents, join the Traders Heaven today! Link Below. Disclaimer: All content of Golden Dragon has only educational and informational purposes, and never should be used or take it as financial advice. Hi, today we are going to talk about the Walmart and its current landscape.
NASDAQ:DLTR
by Igor-Silva
DLTR - DAILY CHARTHi, today we are going to talk about the Dollar Tree and its current landscape. Yesterday, the Food and Drug Administration (FDA) that held its committee meeting today for a series of deliberations, among them the FDA issued to the Dollar Tree a warning about the company has sold potentially unsafe drugs in its stores. These drugs had origin on certain manufactures that were warned by the FDA last year over multiples violations. Dollar Tree will disclosure its earnings on Nov. 26 and can disclosure the possibles impacts of FDA warning on its next quarter guidance. Thank you for reading and leave your comments if you like. To have access to our exclusive contents, join the Traders Heaven today! Link Below. Disclaimer: All content of Golden Dragon has only educational and informational purposes, and never should be used or take it as financial advice.
NASDAQ:DLTR
by Igor-Silva